Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Open Label Study to Assess Efficacy of 5-day Defibrotide Treatment for Hepatic SOS/VOD

NCT04313036 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.

NCT NCT04313036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04313036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Open Label Study to Assess Efficacy of 5-day Defibrotide Treatment for Hepatic SOS/VOD
Lead sponsor
Loyola University
Phase
Phase 2
Overall status
Unknown status
Start date
March 11, 2021
Completion date
August 1, 2022
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow transplant complications, sinusoidal obstruction syndrome, veno-occlusive disease